Climate and the Nephrologist: The Intersection of Climate Change, Kidney Disease, and Clinical Care [0.03%]
气候与肾脏病学：气候变化、肾脏疾病和临床护理的交叉点
Sarah E Young,Laveen J Khoshnaw,Richard J Johnson
Sarah E Young
Climate change is upon us, and it will have a major effect on both kidney disease and the nephrology practice. But the converse is also true: our treatment of kidney disease has an effect on the climate. Much attention has focused on how ri...
Can We Turn the Symptom Curve? Symptom Trajectories and Outcomes among Patients with CKD [0.03%]
我们能让症状曲线发生改变吗？CKD患者的症状轨迹及结局
Giselle Rodriguez de Sosa,Mark Unruh
Giselle Rodriguez de Sosa
Moustapha Faye,Karine Legrand,Lisa Le Gall et al.
Moustapha Faye et al.
Background and objectives: Late stages of CKD are characterized by significant symptom burden. This study aimed to identify subgroups within the 5-year trajectories of symptom evolution in patients with CKD and to describ...
The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis [0.03%]
抗B细胞活化因子治疗狼疮性肾炎的作用
Benjamin Wooden,Jai Radhakrishnan
Benjamin Wooden
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study [0.03%]
贝利木单抗治疗狼疮性肾炎患者的疗效和安全性——BLISS-LN研究开放延伸部分
Richard Furie,Brad H Rovin,Frédéric Houssiau et al.
Richard Furie et al.
Background and objectives: In the BLISS-LN study, belimumab improved kidney outcomes in adult patients with active lupus nephritis. This 28-week open-label extension of BLISS-LN assessed belimumab's safety and efficacy. ...
Randomized Controlled Trial
Clinical journal of the American Society of Nephrology : CJASN. 2022 Nov;17(11):1620-1630. DOI:10.2215/CJN.02520322 2022
Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation [0.03%]
儿童肾移植受者中供体来源细胞游离DNA的纵向评估
Raja Dandamudi,Hongjie Gu,Charles W Goss et al.
Raja Dandamudi et al.
Background and objectives: Donor-derived cellfree DNA (cfDNA) is a less-invasive marker of allograft injury compared with kidney biopsy. However, donor-derived cfDNA has not yet been extensively tested in children, where ...
Nephrology Program Director Protected Time for Program Administration in the United States [0.03%]
美国肾脏病培训项目主任管理工作的独立时间分析
Christina M Yuan,Brian Y Young,Maura A Watson et al.
Christina M Yuan et al.
Background and objectives: The Accreditation Council for Graduate Medical Education (ACGME) required that program directors receive 10-20 h/wk of protected time for program administration (including didactic teaching). In...
Understanding Public Perspectives on Opt-Out Deceased Donor Transplant Policy: Ethically Obligatory and Practically Necessary [0.03%]
理解公众对自动器官捐献政策的观点：符合伦理和实践的必要性
Catherine R Butler
Catherine R Butler
A Qualitative Content Analysis of Comments on Press Articles on Deemed Consent for Organ Donation in Canada [0.03%]
加拿大新闻文章中关于默认器官捐赠评论的定性内容分析
Danielle E Fox,Maoliosa Donald,Christy Chong et al.
Danielle E Fox et al.
Background and objectives: In 2019, two Canadian provinces became the first jurisdictions in North America to pass deemed consent legislation to increase deceased organ donation and transplantation rates. We sought to exp...